Introduction

This journal package grants pharmacists and healthcare professionals access to the November / December 2024 issue of the South African Pharmaceutical Journal, including a quiz to test knowledge gained and receive a certificate if completed successfully.

The journal provides specific clinical reviews on self-medication topics (symptomatic therapy), information on prescription medication (therapy in clinical context) and provides the pharmacists with essential information for referring customers for early medical attention should it be required. Pharmacovigilance – ensuring the safe and appropriate administration and use of medication and reporting of serious adverse events or other adverse drug reactions – is strongly advocated in SAPJ. The SAPJ further supports pharmacists to transform the pharmacy in an accessible, basic primary health care facility for preventing and treating PHC conditions through diagnosis, screening and treatment.

Who Should Enrol

All registered pharmacy- and healthcare professionals in Kenya.

Course Content

The November / December 2024 issue of the South African Pharmaceutical Journal include the following:

Original Research

  • Evaluation of the labelling adherence of the food-associated effects of selected pharmacotherapy

Review

  • Exploring treatment awareness and adherence among type 2 diabetes patients in Lahore, Pakistan
  • Mental health update – Update on depression with a focus on vortioxetine
  • Semaglutide (Ozempic®): A comprehensive review of its pharmacology, efficacy, and safety profile in type 2 diabetes mellitus and weight management

Case Report

  • The use of lenvatinib and pembrolizumab after platinum-based chemotherapy in advanced endometrial cancer

Opinion Piece

  • Pharmaceutical waste disposal

Forum

  • Health Systems Strengthening in the context of Universal Health Coverage

Certification

The assessment (MCQ) must be successfully completed to receive your certificate - two (2) attempts to achieve 70%.

The quiz is based on the following three (3) articles:

  • Evaluation of the labelling adherence of the food-associated effects of selected pharmacotherapy
  • Mental health update – Update on depression with a focus on vortioxetine
  • Semaglutide (Ozempic®): A comprehensive review of its pharmacology, efficacy, and safety profile in type 2 diabetes mellitus and weight management




Sponsored


Access

7 Articles & Quiz for a CPD Certificate included within this Journal Issue